S

Stenocare A/S
CSE:STENO

Watchlist Manager
Stenocare A/S
CSE:STENO
Watchlist
Price: 1.3 DKK
Market Cap: 26m DKK
Have any thoughts about
Stenocare A/S?
Write Note

Stenocare A/S
Long-Term Investments

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Stenocare A/S
Long-Term Investments Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Long-Term Investments CAGR 3Y CAGR 5Y CAGR 10Y
S
Stenocare A/S
CSE:STENO
Long-Term Investments
kr494.4k
CAGR 3-Years
0%
CAGR 5-Years
142%
CAGR 10-Years
N/A
Novo Nordisk A/S
CSE:NOVO B
Long-Term Investments
kr2B
CAGR 3-Years
5%
CAGR 5-Years
0%
CAGR 10-Years
10%
H Lundbeck A/S
CSE:HLUN A
Long-Term Investments
kr99m
CAGR 3-Years
-5%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
ALK-Abello A/S
CSE:ALK B
Long-Term Investments
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

Stenocare A/S
Glance View

Market Cap
23.6m DKK
Industry
Pharmaceuticals

Stenocare A/S engages in the cultivation, manufacture, and distribution of medical cannabis products. The Company’s business model has two divisions: Import and wholesale of finished medical cannabis products for Danish patients, as well as Operate own cultivation- and production facility in Denmark to produce finished cannabis products for Danish and European patients. The firm distributes its products through pharmacies and hospitals. Stenocare's head office is located in Randers, Denmark.

STENO Intrinsic Value
0.45 DKK
Overvaluation 66%
Intrinsic Value
Price
S

See Also

What is Stenocare A/S's Long-Term Investments?
Long-Term Investments
494.4k DKK

Based on the financial report for Dec 31, 2023, Stenocare A/S's Long-Term Investments amounts to 494.4k DKK.

What is Stenocare A/S's Long-Term Investments growth rate?
Long-Term Investments CAGR 5Y
142%

Over the last year, the Long-Term Investments growth was 0%.

Back to Top